Analysts Set Celcuity, Inc. (NASDAQ:CELC) Price Target at $28.40

Shares of Celcuity, Inc. (NASDAQ:CELC - Get Free Report) have been assigned a consensus recommendation of "Buy" from the six ratings firms that are covering the firm, MarketBeat.com reports. Five equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $28.40.

A number of research analysts recently issued reports on CELC shares. Needham & Company LLC reiterated a "buy" rating and issued a $29.00 target price on shares of Celcuity in a report on Monday, June 30th. HC Wainwright reiterated a "buy" rating and issued a $27.00 target price on shares of Celcuity in a report on Monday, May 19th. Finally, Stifel Nicolaus assumed coverage on Celcuity in a report on Tuesday, July 1st. They set a "buy" rating and a $30.00 price target for the company.

Institutional Trading of Celcuity

A number of institutional investors have recently bought and sold shares of the business. Baker BROS. Advisors LP lifted its holdings in shares of Celcuity by 59.0% in the 1st quarter. Baker BROS. Advisors LP now owns 4,257,735 shares of the company's stock valued at $43,046,000 after purchasing an additional 1,579,182 shares during the last quarter. Soleus Capital Management L.P. lifted its holdings in shares of Celcuity by 106.0% in the 4th quarter. Soleus Capital Management L.P. now owns 2,565,087 shares of the company's stock valued at $33,577,000 after purchasing an additional 1,319,700 shares during the last quarter. Janus Henderson Group PLC purchased a new stake in shares of Celcuity in the 4th quarter valued at about $8,468,000. Ameriprise Financial Inc. lifted its holdings in shares of Celcuity by 45.9% in the 4th quarter. Ameriprise Financial Inc. now owns 447,171 shares of the company's stock valued at $5,853,000 after purchasing an additional 140,642 shares during the last quarter. Finally, Artisan Partners Limited Partnership lifted its holdings in shares of Celcuity by 18.2% in the 4th quarter. Artisan Partners Limited Partnership now owns 491,507 shares of the company's stock valued at $6,434,000 after purchasing an additional 75,830 shares during the last quarter. 63.33% of the stock is owned by hedge funds and other institutional investors.

Celcuity Trading Up 0.1%

Shares of NASDAQ CELC traded up $0.01 during trading on Tuesday, reaching $13.63. The stock had a trading volume of 171,535 shares, compared to its average volume of 276,078. The company has a market cap of $516.17 million, a P/E ratio of -4.50 and a beta of 0.45. The business's 50-day moving average price is $11.71 and its 200-day moving average price is $11.30. Celcuity has a fifty-two week low of $7.58 and a fifty-two week high of $19.77. The company has a debt-to-equity ratio of 1.14, a quick ratio of 6.61 and a current ratio of 6.61.

Celcuity (NASDAQ:CELC - Get Free Report) last released its earnings results on Wednesday, May 14th. The company reported ($0.86) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.95) by $0.09. On average, equities research analysts predict that Celcuity will post -2.62 EPS for the current fiscal year.

About Celcuity

Celcuity Inc, a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.